Novartis (Sweden)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2011

  1. Why a Bayesian approach to safety analysis in pharmacovigilance is important

    Pharmaceutical Statistics, Vol. 10, Núm. 6, pp. 554-559